Goles, Nerie G.

HRN: 27 22 01  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/27/2025
CEFTAZIDIME 1GM (VIAL)
07/27/2025
08/03/2025
IV
1gm
Q8
VAP
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: